Brief: 10X Genomics Q4 Operating Income USD -49.8 Million Vs. IBES Estimate USD -40.5 Million
12/02/2025 21:05
Feb 12 (Reuters) - 10X Genomics Q4 gross margin 67%. * Q4 net income USD -49 million vs. IBES estimate USD -37.4 million * outlook FY revenue USD 610-630 million
Recent news on 10x Genomics
See all newsBrief: 10X Genomics Announces New Collaboration To Advance Single Cell And Spatial Applications Across Solid Tumors And Blood Cancers
U.S. RESEARCH ROUNDUP-Autodesk, Hubspot, Oracle
Delaware jury finds Parse infringed three genetic-sequencing patents (updated)
Qiagen owes 10x, Roche $4.8 million for infringing patents, U.S. jury says
Brief: 10X Genomics Wins Patent Infringement Verdict Against Parse Biosciences